1.Von Hippel-Lindau disease: A Case Report.
Kyung Ran KO ; Joo Won LIM ; Bum Ha YI ; Dong Ho LEE ; Young Tai KO
Journal of the Korean Radiological Society 2002;46(1):45-48
Von Hippel-Lindau disease is an autosomal dominant disorder characterized by the presence of multiple benign and malignant tumors including hemangioblastomas of the retina and central nervous system, pancreatic cysts and tumors, renal cell carcinomas, pheochromocytomas and epididymal cystadenomas. We report the radiologic findings of a case of von Hippel-Lindau disease, describing the family history.
Carcinoma, Renal Cell
;
Central Nervous System
;
Cystadenoma
;
Hemangioblastoma
;
Humans
;
Pancreatic Cyst
;
Pheochromocytoma
;
Retina
;
von Hippel-Lindau Disease*
2.Comparison of Laser Epithelial Keratomileusis(LASEK) in One Eye and Photorefractive Keratectomy(PRK) in Other Eye for Low to Moderate Myopia.
Ha Young KONG ; Il Hwan KO ; Jae Bum LEE
Journal of the Korean Ophthalmological Society 2001;42(6):825-831
PURPOSE: To assess effectiveness, safety and stability of laser epithelial keratomileusis(LASEK), versus conventional photorefractive keratectomy(PRK) for low to moderate myopia. METHODS: 27 patients with a manifest refraction of -3.00 to -6.50 diopters were treated and followed-up for 3 months. In each case, one eye received PRK and the other LASEK. The surgical method and the sequence between the eyes were randomized. Postoperative pain, epithelial healing time, uncorrected visual acuity, manifest refraction, corneal haze and surgical preference were examined after the operation. RESULTS: During a 3-month-follow-up, we found no significant differences in epithelial healing time, uncorrected visual acuity and refractive error. However, LASEK treated eyes had lower postoperative pain scores(P=0.047), and corneal haze scores(1 month; P=0.02) than those of PRK. Seventeen patients(63%) preferred the LASEK procedure. CONCLUSION: LASEK and PRK has an equal effect in correction of myopia, but LASEK reduced incidence of postoperative pain and early postoperative corneal haze. This suggests LASEK can be an alternative procedure for correction of low to moderate myopia.
Humans
;
Incidence
;
Keratectomy, Subepithelial, Laser-Assisted
;
Myopia*
;
Pain, Postoperative
;
Refractive Errors
;
Visual Acuity
3.Antiepileptic and Neuroprotective Effect of Ketamine in Lithium-Pilocarpine Induced Status Epilepticus Rat Model.
Seok Bum KO ; Soung Kyeong PARK ; Young Min SHON ; Yeong In KIM
Journal of Korean Epilepsy Society 2004;8(1):26-30
PURPOSE: To examine the putative seizure-protective properties of ketamine in lithium-pilocarpine induced status epilepticus (LPSE). METHODS: Lithium chloride followed 24 h later by pilocarpine was administered for seizure induction. Ketamine (40 mg/kg) or phenytoin (50 mg/kg) was injected intraperitoneally 10 min or 60 min after the onset of continuous ictal discharge. Then the seizure behavior and EEG were observed and histological changes were compared through Nissl stain at 72 hours. RESULTS: The antiepileptic effect of ketamine, injected during the early stages of LPSE (10 min after the onset of continuous ictal discharge), was comparable to that of phenytoin. Ketamine was more effective than phenytoin in decreasing spike frequency, when administered on the plateau of LPSE (injection 60 min after onset of continuous ictal discharge electrographically). Anticonvulsant action of ketamine was confirmed by a less neuronal injury in hippocampus compared with control rats injected with phenytoin. CONCLUSIONS: In prolonged status epilepticus rat model, ketamine was effective as an antiepileptic, but phenytoin was not. Ketamine was also neuroprotective on the neuronal injury in the hippocampus. These results suggest that ketamine might be useful as an antiepileptic drug when standard antiepileptic drugs fail in the treatment of the refractory cases of status epilepticus.
Animals
;
Anticonvulsants
;
Electroencephalography
;
Hippocampus
;
Ketamine*
;
Lithium Chloride
;
Models, Animal*
;
Neurons
;
Neuroprotective Agents*
;
Phenytoin
;
Pilocarpine
;
Rats*
;
Seizures
;
Status Epilepticus*
4.Ultrasound-Guided Injections in the Lumbar and Sacral Spine
Kwang Pyo KO ; Jae Hwang SONG ; Whoan Jeang KIM ; Sang Bum KIM ; Young Ki MIN
Journal of Korean Society of Spine Surgery 2018;25(4):185-195
STUDY DESIGN: Literature review. OBJECTIVE: Ultrasound-guided injections are a common clinical treatment for lower lumbosacral pain that are usually performed before surgical treatment if conservative treatment fails. The aim of this article was to review ultrasound-guided injections in the lumbar and sacral spine. SUMMARY OF LITERATURE REVIEW: Ultrasound-guided injections, unlike conventional interventions using computed tomography or C-arm fluoroscopy, can be performed under simultaneous observation of muscles, ligaments, vessels, and nerves. Additionally, they have no radiation exposure and do not require a large space for the installation of equipment, so they are increasingly selected as an alternative method. MATERIALS AND METHODS: We searched for and reviewed studies related to the use of ultrasound-guided injections in the lumbar and sacral spine. RESULTS: In order to perform accurate ultrasound-guided injections, it is necessary to understand the patient's posture during the intervention, the relevant anatomy, and normal and abnormal ultrasonographic findings. Facet joint intra-articular injections, medial branch block, epidural block, selective nerve root block, and sacroiliac joint injections can be effectively performed under ultrasound guidance. CONCLUSIONS: Ultrasound-guided injections in the lumbar and sacral spine are an efficient method for treating lumbosacral pain.
Fluoroscopy
;
Injections, Intra-Articular
;
Ligaments
;
Methods
;
Muscles
;
Posture
;
Radiation Exposure
;
Sacroiliac Joint
;
Spine
;
Ultrasonography
;
Zygapophyseal Joint
5.Ultrasound-Guided Injections in the Lumbar and Sacral Spine
Kwang Pyo KO ; Jae Hwang SONG ; Whoan Jeang KIM ; Sang Bum KIM ; Young Ki MIN
Journal of Korean Society of Spine Surgery 2018;25(4):185-195
OBJECTIVE:
Ultrasound-guided injections are a common clinical treatment for lower lumbosacral pain that are usually performed before surgical treatment if conservative treatment fails. The aim of this article was to review ultrasound-guided injections in the lumbar and sacral spine.SUMMARY OF LITERATURE REVIEW: Ultrasound-guided injections, unlike conventional interventions using computed tomography or C-arm fluoroscopy, can be performed under simultaneous observation of muscles, ligaments, vessels, and nerves. Additionally, they have no radiation exposure and do not require a large space for the installation of equipment, so they are increasingly selected as an alternative method.
MATERIALS AND METHODS:
We searched for and reviewed studies related to the use of ultrasound-guided injections in the lumbar and sacral spine.
RESULTS:
In order to perform accurate ultrasound-guided injections, it is necessary to understand the patient's posture during the intervention, the relevant anatomy, and normal and abnormal ultrasonographic findings. Facet joint intra-articular injections, medial branch block, epidural block, selective nerve root block, and sacroiliac joint injections can be effectively performed under ultrasound guidance.
CONCLUSIONS
Ultrasound-guided injections in the lumbar and sacral spine are an efficient method for treating lumbosacral pain.
6.Morphologic change of pulmonary arteries and right ventricular outflow tract after total correction of tetralogy of Fallot: risk factors for pulmonary artery junctional stenosis.
Jin Sung KO ; Jae Young CHOI ; Jong Kyun LEE ; Kyung Eun KIM ; Jun Hee SUL ; Seung Kyu LEE ; Young Hwan PARK ; Bum Goo CHO
Korean Circulation Journal 2001;31(2):238-245
BACKGROUND AND OBJECTIVES: Recently, the result of total correction in tetralogy of Fallot(TOF) is improved dramatically. But, residual anatomical changes of right ventricular outflow tract(RVOT) and pulmonary artery junctional stenosis result in bad prognosis. Therefore we sought to analyze risk factors for pulmonary artery junctional stenosis after correction of TOF. METHODS: From 1991 to 1998, 146 patients underwent the follow-up catheterizations after total correction of TOF in our institution and were analysed risk factors for pulmonary artery junctional stenosis. Of this patients group [age on operation 20.119.8 months, follow-up duration after operation 13.95.0 months, male(64%)], 20 cases(13.7%) had a PDA and 26 cases(17.8%) had a systemic-to-pulmonary shunt operation before total correction of TOF. RESULTS: 1) Residual PS is correlated significantly with post-operative RVP/LVP(r=.776, p<0.01) and post-operative RVEDP(r=.196, p<0.05). 2) Post-operative RVP/LVP and residual PS increased significantly in grade II of residual PI than grade III~IV. 3) The left pulmonary artery junctional stenosis(LPAJS) was observed in 31 cases, this group decreased significantly in pre-operative LPA diameter(p<0.01), increased in post-operative RVP/LVP(p<0.01), and increased in post-operative RPA diameter(p<0.01), decreased in post-operative LPA diameter(p<0.01) and was more severe in post-operative PI(p<0.01) than the other group respectively. 4) Of the patients group which went patch enlargement of RVOT to LPA junction, the pressure gradient on LPA junction increased significantly in PDA and false aneurysmal change. 5) Factors significantly associated with pulmonary artery junctional stenosis were patch enlargement of RVOT to LPA junction, aneurysmal change of RVOT, PDA, systemic-to-pulmonary shunt and pre-operative LPAJS. 6) LPAJS(P, mmHg) =5.43 +16.24*[false aneurysmal change of RVOT] +14.13*[RVOT patch enlargement to LPA] +16.89*PDA. CONCLUSION: Several factors significantly associated with pulmonary artery junctional stenosis influenced each other. And the LPAJS led to secondary changes (volume overload of RV, increasing diameter of RPA, et. al) therefore more active diagnosis and treatment after total correction is recommended.
Aneurysm
;
Aneurysm, False
;
Catheterization
;
Catheters
;
Constriction, Pathologic*
;
Diagnosis
;
Follow-Up Studies
;
Humans
;
Prognosis
;
Pulmonary Artery*
;
Risk Factors*
;
Tetralogy of Fallot*
7.Multiplex polymerase chain reaction test for the diagnosis of acute viral hepatitis A.
Nae Yun HEO ; Young Suk LIM ; Jihyun AN ; Sun Young KO ; Heung Bum OH
Clinical and Molecular Hepatology 2012;18(4):397-403
BACKGROUND/AIMS: The early diagnosis of acute hepatitis A (AHA) is hindered because serum IgM against hepatitis A virus (HAV) can yield false-negative results during the window period. This study evaluated the diagnostic accuracy of a polymerase chain reaction (PCR) kit for HAV RNA for the diagnosis of AHA. METHODS: Samples were collected from 136 patients with acute severe hepatitis at their admission to Asan Medical Center between June 2010 and July 2010. Samples were analyzed for serum IgM anti-HAV using an immunoassay test and for qualitative HAV RNA using the Magicplex HepaTrio PCR test kit. The diagnostic accuracies of these methods were tested on the basis of clinical and laboratory diagnoses of AHA. RESULTS: The concordance rate and kappa value between IgM anti-HAV and HAV RNA PCR were 88.2% and 0.707, respectively. For the diagnosis of AHA, the sensitivity and specificity of IgM anti-HAV were 90.7% and 100%, respectively, when an "equivocal" result was regarded as positive; and 79.1% and 100%, respectively, when an "equivocal" result was regarded as negative. The sensitivity and specificity of HAV RNA PCR were 81.4% and 100%, respectively. All four patients with negative IgM anti-HAV and positive HAV RNA PCR results and all four patients with equivocal IgM anti-HAV RNA and positive HAV RNA PCR results were eventually diagnosed with AHA. CONCLUSIONS: The qualitative HAV RNA PCR test has an equivalent diagnostic accuracy for AHA compared to IgM anti-HAV and may be more sensitive during the window period.
Acute Disease
;
Adult
;
Aged
;
Female
;
Hepatitis A/*diagnosis
;
Hepatitis A virus/genetics/immunology
;
Humans
;
Immunoassay
;
Immunoglobulin M/blood
;
Male
;
Middle Aged
;
*Multiplex Polymerase Chain Reaction
;
Prospective Studies
;
RNA, Viral/*blood
;
Reagent Kits, Diagnostic
;
Sensitivity and Specificity
8.Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor.
Hoon CHOI ; Young Seop CHANG ; Byung Hun PARK ; Dong Hoon KO ; Young Joon MOON ; Jin Bum KIM
Korean Journal of Andrology 2012;30(1):45-51
PURPOSE: To compare the clinical therapeutic efficacy of finasteride and dutasteride as 5-alpha reductase inhibitor (5-ARI) in the medical treatment of benign prostate hyperplasia. MATERIALS AND METHODS: From July 2007 to July 2010, 354 benign prostatic hyperplasia patients with combination medication : alpha blocker plus 5-ARI were enrolled. These patients were classified into a finasteride medication group (F group) and dutasteride medication group (D group) retrospectively. We initially measured the total prostate volume (TPV), prostate specific antigen (PSA), International Prostate Symptom Score (IPSS), quality of life score (QoL), maximal flow rate (Qmax), and post-void residual urine (PVR). After at least twelve months of medication, we rechecked these clinical parameters and during medication, side effects related to medication were also recorded. RESULTS: The F group (n=129) and D group (n=225) showed no differences in baseline characteristics for age, TPV, IPSS, QoL scores, or PSA. After medication, decreases in TPV were relatively higher in the D group than the F group (28.2% vs 20.5%). In addition, the decrease in PSA (43.6% vs 39.2%) and IPSS score (4.6 vs 3.5) were also higher in the D group. There were no significant differences in QoL score, Qmax, PVR change, or side effects between the two groups. CONCLUSIONS: Dutasteride showed greater efficacy in reduction of TPV and PSA and in symptomatic improvement by IPSS score than finasteride. More large scale studies about the differences on clinical efficacy of finasteride and dutasteride are needed.
5-alpha Reductase Inhibitors
;
Azasteroids
;
Finasteride
;
Humans
;
Oxidoreductases
;
Prostate
;
Prostate-Specific Antigen
;
Prostatic Hyperplasia
;
Quality of Life
;
Retrospective Studies
;
Dutasteride
9.A Case Report of Castleman's Disease(Giant Lymph Node Hyperplasia) Presenting as a Isolated Neck Mass.
See Young PARK ; Sang Chul KIM ; Young Seung KO ; Seung Bum KIM
Korean Journal of Otolaryngology - Head and Neck Surgery 2004;47(9):935-938
Castleman's disease, a benign lymphoproliferative disease of unknown etiology, rarely occures as a neck mass. Only 6% of the cases reported in the literature was detected primarily in the neck. This disease consists of unicentric or multicentric (or systemic) forms by clinical manifestation and hyaline vascular type or plasma cell type, histologically. The more common hyaline vascular type usually presents as an asymptomatic lymphoid mass. On the other hand, in plasma cell type, systemic manifestations are frequently observed. Definite diagnosis and treatment is possible with complete surgical resection following histologic evaluation. Recently, we experienced a 22 year old woman patient with 5 year history of right neck mass. She underwent surgical mass resection. Pathologic analysis confirmed hyaline vascular variant of Castleman's disease. Now, we report this case with a review of previously reported literature.
Diagnosis
;
Female
;
Giant Lymph Node Hyperplasia
;
Hand
;
Humans
;
Hyalin
;
Lymph Nodes*
;
Neck*
;
Plasma Cells
;
Young Adult
10.An Unusual Case of Luetic Lymphadenitis as a Solitary Submandibular Mass.
See Young PARK ; Bum Jo JUNG ; Young Seung KO ; Chang Ho SEONG
Korean Journal of Otolaryngology - Head and Neck Surgery 2009;52(10):849-851
Syphilis, a chronic systemic infection caused by Treponema pallidum, is usually sexually transmitted and characterized by episodes of active disease interrupted by a latent period. After an incubation period of averaging 2-6 weeks, a primary syphilis with a firm, non-tender chancre appears, often associated with regional lymphadenopathy. Secondary syphilis shows localized or diffuse mucocutaneous lesions and generalized non-tender lymphadenopathy. In about onethird of untreated cases, the tertiary stage appears, characterized by progressive destructive mucocutaneous, musculoskeletal or parenchymal lesions, aortitis or symptomatic central nervous system diseases. Without serological testing, the precise diagnosis is very difficult. In fact, it has often been called the great imitator because it was often confused with other disease. We report a very unusual case of luetic lymphadenitis presented as a solitary submandibular mass.
Aortitis
;
Central Nervous System Diseases
;
Chancre
;
Lymphadenitis
;
Lymphatic Diseases
;
Neck
;
Serologic Tests
;
Syphilis
;
Treponema pallidum